イセキ ヒロシ
Iseki Hiroshi
伊関 洋 所属 医学研究科 医学研究科 (医学部医学科をご参照ください) 職種 特任顧問 |
|
言語種別 | 英語 |
種別 | 部分執筆 |
表題 | Do We Really Still Need an Open Surgery for Treatment
of Patients with Vestibular Schwannomas? |
書名 | Gamma Knife Neurosurgery in the Management of Intracranial Disorders |
ISBNコード | 9783709113752 |
編者名 | Mikhail Chernov,Motohiro Hayashi,Jeremy Ganz,Kintomo Takakura |
版・巻・頁 | 116,pp.25-36 |
出版社 | Springer |
出版地 (都市, 国名) | Wien,Austria |
著者・共著者 | HAYASHI Motohiro, CHERNOV Mikhail, Samuel M. Lipski, TAMURA Noriko, Shoji Yomo, MATSUOKA Ayako, TSUZUKI Syunsuke, IZAWA Masahiro, OKADA Yoshikazu, MURAGAKI Yoshihiro, ISEKI Hiroshi, Pavel Ivanov, Jean Regis, TAKAKURA Kintomo |
発行年月 | 2013/03 |
概要 | Abstract
BACKGROUND: Gamma Knife surgery (GKS) should be considered a standard treatment option for small and medium-sized vestibular schwannomas (VSs). It results in a tumor control rate similar to that seen with microsurgery and provides better preservation of facial nerve function and hearing. METHODS: From December 2002 to April 2011, a total of 260 patients with VS underwent GKS using Leksell Gamma Knife model 4C with an automatic positioning system. There were 30 Koos stage I tumors, 112 stage II, 100 stage III, and 18 stage IV. All patients were treated with the use of high-resolution magnetic resonance imaging; creation of the highly precise conformal and selective multi-isocenter dose planning with small collimators, carefully sparing adjacent cranial nerves of any excessive irradiation; and creation of a wide 80 % isodose area within the tumor while applying a low marginal dose (mean 11.9 Gy) at the 50 % isodose line. RESULTS: Among 182 patients who were followed for more than 3 years after treatment, the tumor control and shrinkage rates were 98.4 % and 76.4 %, respectively. Volume reduction of >50 % was marked in 54.9 % of VSs. Preservation of facial nerve function and hearing at the pretreatment level was noted in 97.8 % and 87.9 %, respectively. There was marked improvement of facial nerve function and hearing after GKS in 2.2 % and 3.8 %, respectively. There was no major morbidity. CONCLUSION: Due to contemporary technological and methodological achievements GKS can be focused not only on growth control but on shrinking the VS, with possible reversal of the neurological deficit. |